Predominance of IgG1 and IgG3 subclasses of autoantibodies to peptidylarginine deiminase 4 in rheumatoid arthritis

被引:0
作者
Wei Wang
Jinming Li
机构
[1] Chinese Academy of Medical Sciences,Graduate School, Peking Union Medical College
[2] Beijing Hospital,National Center for Clinical Laboratories
来源
Clinical Rheumatology | 2011年 / 30卷
关键词
Autoantibody; Immunoglobulin G; Peptidylarginine deiminase 4; Rheumatoid arthritis; Subclass;
D O I
暂无
中图分类号
学科分类号
摘要
Analysis of IgG subclass distribution of antibodies may provide insights into the mechanisms driving antibody production. Here, we have first determined IgG subclass distribution of anti-recombinant peptidylarginine deiminase 4 (anti-hPADI4) antibodies in sera from patients with rheumatoid arthritis (RA). Sera from 103 RA patients were screened to IgG anti-PADI4 using recombinant antigens. For positive samples, the subclass distribution of IgG anti-hPADI4 was determined by means of establishing the equipotency of four HRP-labeled IgG subclass-specific monoclonal antibodies. The subclass profiles were compared among individuals with different disease status. Thirty-three out of 103 RA patients were determined as IgG anti-hPADI4-positive. As expressed by percentage levels to total IgG anti-hPADI4 activity, IgG1 and IgG3 were determined to be the predominant subclasses of anti-hPADI4. Furthermore, distinct subclass distribution patterns were observed in patients with different disease status. The IgG subclass distribution of anti-hPADI4 indicates that a leading T lymphocyte-regulated IgG1 and IgG3 responses may contribute to a better understanding of the role of anti-PADI4 in RA.
引用
收藏
页码:563 / 567
页数:4
相关论文
共 110 条
  • [1] Suzuki A(2007)Citrullination by peptidylarginine deiminase in rheumatoid arthritis Ann NY Acad Sci 1108 323-339
  • [2] Yamada R(2008)Antibodies to citrullinated proteins in arthritis: pathology and promise Curr Opin Rheumatol 20 300-305
  • [3] Yamamoto K(2005)Peptidylarginine deiminase 4 (PADI4) identified as a conformation-dependent autoantigen in rheumatoid arthritis Scand J Rheumatol 34 212-215
  • [4] Klareskog L(2008)Serum IgG antibodies to peptidylarginine deiminase 4 in rheumatoid arthritis and associations with disease severity Ann Rheum Dis 67 414-417
  • [5] Widhe M(2009)Serum IgG antibodies to peptidylarginine deiminase 4 predict radiographic progression in patients with rheumatoid arthritis treated with tumour necrosis factor-alpha blocking agents Ann Rheum Dis 68 249-252
  • [6] Hermansson M(2008)Prevalence and significance of anti-peptidylarginine deiminase 4 antibodies in rheumatoid arthritis J Rheumatol 35 969-974
  • [7] Rönnelid J(2008)Association of autoimmunity to peptidyl arginine deiminase type 4 with genotype and disease severity in rheumatoid arthritis Arthritis Rheum 58 1958-1967
  • [8] Takizawa Y(2009)New autoantigens in rheumatoid arthritis (RA): screening 8268 protein arrays with sera from patients with RA Ann Rheum Dis 68 591-594
  • [9] Sawada T(1988)The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis Arthritis Rheum 31 315-324
  • [10] Suzuki A(1998)Validation of rheumatoid arthritis improvement criteria that include simplified joint counts Arthritis Rheum 41 1845-1850